Osivax Receives Over USD 1.5M Grant from NIAID to Advance Development of Broad-Spectrum Influenza Vaccine Candidate, OVX836
Grant to support preclinical evaluation of OVX836 in providing protection against pandemic influenza strains OVX836 has already been evaluated in...




















